-
421
Total penectomy as treatment option for solitary penile metastasis in hormone sensitive metastatic prostate cancer (mHSPC): Case report with surgical technique
Published 2025-01-01“…We present a case of a 66-year-old man with a three-year history of Gleason 10 prostate cancer (PCa), who presented with penile pain, erythema, and induration of the penile shaft. …”
Get full text
Article -
422
Enhancing in Vitro anti-metastatic efficacy and deep penetration into tumor spheroid of docetaxel-loaded liposomes via size optimization for prostate cancer treatment
Published 2025-03-01Subjects: “…Prostate cancer…”
Get full text
Article -
423
-
424
-
425
Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients
Published 2015-01-01“…Prostate Cancer…”
Get full text
Article -
426
Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology Setting
Published 2024-08-01“…**Background:** The use of androgen receptor signaling inhibitors, including apalutamide, in combination with androgen deprivation therapy is recommended for the treatment of metastatic castration-sensitive prostate cancer (mCSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). …”
Get full text
Article -
427
Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men
Published 2012-01-01“…Prostate Cancer…”
Get full text
Article -
428
-
429
An MRI radiomics model for predicting a prostate-specific antigen response following abiraterone treatment in patients with metastatic castration-resistant prostate cancer
Published 2025-01-01Subjects: “…metastatic castration-resistant prostate cancer…”
Get full text
Article -
430
-
431
-
432
A Cross-sectional Survey of Physicians to Understand Biomarker Testing and Treatment Patterns in Patients with Prostate Cancer in the USA, EU5, Japan, and China
Published 2025-01-01Subjects: “…Metastatic castration-resistant prostate cancer…”
Get full text
Article -
433
Diagnostic Accuracy of Serum Prostate Specific Antigen and Gleason Score in Determining the Presence of Skeletal Metastasis in Prostate Cancer Patients: a Pakistani Perspective
Published 2023-04-01Subjects: “…Bone metastasis, bone scan, Gleason score, prostate cancer, prostate specific antigen…”
Get full text
Article -
434
-
435
Ascertaining provider-level implicit bias in electronic health records with rules-based natural language processing: A pilot study in the case of prostate cancer.
Published 2024-01-01“…<h4>Methods and findings</h4>Patients ≥18 years with a diagnosis of very-low to favorable intermediate-risk prostate cancer followed by 3 urologic oncologists from 2010 through 2021. …”
Get full text
Article -
436
Curcumin inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells via IGF-1/PI3K/Akt pathway
Published 2025-02-01“…Objective This study aimed to investigate the possible mechanism by which curcumin inhibits human prostate cancer (PCa) and castration-resistant prostate cancer (CRPC). …”
Get full text
Article -
437
-
438
Study on Apoptosis of Prostate Cancer Cells Induced by IκBα Overexpression Synergistic with Poly (Lactic-Co-Glycolic Acid)-Curcumin Nanoparticles
Published 2021-01-01“…To investigate the synergistic effects of IκBα overexpression and poly (lactic-co-glycolic acid)-curcumin nanoparticles (PLGA-Cur-NPs) on prostate cancer (PC) and reveal the underlying mechanisms of cooperative sensitization induced by curcumin. …”
Get full text
Article -
439
Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settings
Published 2025-02-01Subjects: “…metastatic castration-resistant prostate cancer…”
Get full text
Article -
440
Association between Metformin Use and Cancer Stage at Diagnosis among Elderly Medicare Beneficiaries with Preexisting Type 2 Diabetes Mellitus and Incident Prostate Cancer
Published 2016-01-01“…To examine the association between metformin use and cancer stage at diagnosis among elderly men with preexisting diabetes mellitus and incident prostate cancer. Methods. This study used a population-based observational cohort of elderly men (≥66 years) with preexisting diabetes and incident prostate cancer between 2008 and 2009 (N=2,652). …”
Get full text
Article